Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Vanderbilt University |
---|---|
Information provided by: | Vanderbilt University |
ClinicalTrials.gov Identifier: | NCT00580658 |
The purpose of this study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of the deep brain stimulator device in the treatment of this rare disorder. Use of DBS for dystonia is approved for humanitarian use by the FDA in the treatment of chronic, intractable (drug refractory) dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis) in patients 7 years or older. Thus, this proposal request authorization by the IRB to allow patients at VUMC to access this HUD therapy.
Condition | Intervention |
---|---|
Dystonia |
Device: Medtronic Activa Gpi |
Study Type: | Expanded Access |
Official Title: | Humanitarian Device Exemption for Medtronic Activa Dystonia Therapy |
Study Start Date: | May 2006 |
Estimated Study Completion Date: | May 2020 |
The purpose of this IRB approved study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of the deep brain stimulator device in the treatment of this rare disorder. Use of DBS for dystonia is approved for humanitarian use by the FDA in the treatment of chronic, intractable (drug refractory) dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis) in patients 7 years or older. Thus, this proposal request authorization by the IRB to allow patients at VUMC to access this HUD therapy.
Ages Eligible for Study: | 7 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Tennessee | |
Vanderbilt University | |
Nashville, Tennessee, United States, 37232 |
Principal Investigator: | Peter E Konrad, MD, Ph.D. | Vanderbilt University, Dept. Neurosurgery |
Principal Investigator: | Joseph S Neimat, MD, MS | Vanderbilt University, Dept. Neurosurgery |
Principal Investigator: | Thomas L Davis, MD | Vanderbilt University, Dept. Neurology |
Principal Investigator: | John Y Fang, MD | Vanderbilt University, Dept. Neurology |
Responsible Party: | Vanderbilt University, Dept. Neurosurgery ( Peter E. Konrad, MD, Ph.D. ) |
Study ID Numbers: | 060155 |
Study First Received: | December 13, 2007 |
Last Updated: | December 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00580658 |
Health Authority: | United States: Food and Drug Administration |
Dystonia |
Dystonic Disorders Signs and Symptoms Movement Disorders Central Nervous System Diseases |
Neurologic Manifestations Dystonia Dyskinesias |
Nervous System Diseases |